Association Between Proteinuria and Pregnancy Outcomes in Women With Preterm Pre‐Eclampsia Undergoing Expectant Management: Secondary Analysis of Two Randomised Trials

OBJECTIVE: Evaluate whether proteinuria levels, in women undergoing expectant management for pre-eclampsia, are associated with pregnancy latency and adverse outcomes. DESIGN: Secondary analysis of data from two randomised trials. SETTING: Tygerberg Hospital, Cape Town, South Africa. POPULATION: Women undergoing expectant management for pre-eclampsia diagnosed between 26 and 32 weeks. METHODS: Latency was analysed using parametric time-to-event methods to estimate increases. Composite outcomes were assessed using Poisson regression. MAIN OUTCOME MEASURES: Pregnancy latency Composite adverse maternal or perinatal outcomes. RESULTS: Two hundred and ninety-one women were included. Women with < 3 g/24 h had a median prolongation of 15.3 days (interquartile range (IQR) 4.3 to 25.6), compared to 10.0 days (IQR 5.0 to 19.6) with proteinuria between 3 to 5 g/24 h; and 4.9 days (IQR 3.8 to 11.7) for those with ≥ 5 g/24 h. Increasing levels were also associated with increases in subsequent adverse composite maternal outcomes: 8.8% of women with < 3 g/24 h experienced maternal complications, compared to 16.1% with 3 to 5 g/24 h, and 27.9% with ≥ 5 g/24 h. There was no association with composite perinatal adverse outcomes. The sFlt-1/PIGF ratio performed slightly better in predicting latency (area under the receiver operating characteristic curve (AUC) 0.78 vs. 0.67) but similarly in predicting adverse composite maternal outcomes (AUC 0.67 vs. 0.64). Both had poor performance for predicting composite adverse perinatal outcomes (AUC 0.61 vs. 0.56). CONCLUSION: Levels of proteinuria strongly correlate with pregnancy latency and adverse maternal outcomes, but not perinatal outcomes, in women with pre-eclampsia undergoing expectant management. They perform similarly to angiogenic markers. Proteinuria levels may confer useful prognostic information to assist clinical decision-making.

Authors

Institutions

Publication Details

Journal
BJOG An International Journal of Obstetrics & Gynaecology
Published
2026-09-18
DOI
https://doi.org/10.1111/1471-0528.70335
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Association Between Proteinuria and Pregnancy Outcomes in Women With Preterm Pre‐Eclampsia Undergoing Expectant Management: Secondary Analysis of Two Randomised Trials

Susan Walker, Lina Bergman, Stephen Tong, Henrik Imberg et al.
BJOG An International Journal of Obstetrics & Gynaecology
Pregnancy and preeclampsia studies
article

Association Between Proteinuria and Pregnancy Outcomes in Women With Preterm Pre‐Eclampsia Undergoing Expectant Management: Secondary Analysis of Two Randomised Trials

Susan Walker, Lina Bergman, Stephen Tong, Henrik Imberg, Catherine Cluver, Denise Sproul, Amy van Rooyen
article en

Abstract

OBJECTIVE: Evaluate whether proteinuria levels, in women undergoing expectant management for pre-eclampsia, are associated with pregnancy latency and adverse outcomes. DESIGN: Secondary analysis of data from two randomised trials. SETTING: Tygerberg Hospital, Cape Town, South Africa. POPULATION: Women undergoing expectant management for pre-eclampsia diagnosed between 26 and 32 weeks. METHODS: Latency was analysed using parametric time-to-event methods to estimate increases. Composite outcomes were assessed using Poisson regression. MAIN OUTCOME MEASURES: Pregnancy latency Composite adverse maternal or perinatal outcomes. RESULTS: Two hundred and ninety-one women were included. Women with < 3 g/24 h had a median prolongation of 15.3 days (interquartile range (IQR) 4.3 to 25.6), compared to 10.0 days (IQR 5.0 to 19.6) with proteinuria between 3 to 5 g/24 h; and 4.9 days (IQR 3.8 to 11.7) for those with ≥ 5 g/24 h. Increasing levels were also associated with increases in subsequent adverse composite maternal outcomes: 8.8% of women with < 3 g/24 h experienced maternal complications, compared to 16.1% with 3 to 5 g/24 h, and 27.9% with ≥ 5 g/24 h. There was no association with composite perinatal adverse outcomes. The sFlt-1/PIGF ratio performed slightly better in predicting latency (area under the receiver operating characteristic curve (AUC) 0.78 vs. 0.67) but similarly in predicting adverse composite maternal outcomes (AUC 0.67 vs. 0.64). Both had poor performance for predicting composite adverse perinatal outcomes (AUC 0.61 vs. 0.56). CONCLUSION: Levels of proteinuria strongly correlate with pregnancy latency and adverse maternal outcomes, but not perinatal outcomes, in women with pre-eclampsia undergoing expectant management. They perform similarly to angiogenic markers. Proteinuria levels may confer useful prognostic information to assist clinical decision-making.

BJOG An International Journal of Obstetrics & Gynaecology
Translational Research Institute (AU), Stellenbosch University (ZA), Mercy Hospital for Women (AU), Kemakta Konsult (SE), Statisticon (Sweden) (SE), University of Gothenburg (SE)
Openalex Percentile: Top 8%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.